Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
2009 Standout
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
2010 Standout
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma
2012
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
2014
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Restaging laparotomy in the management of the non‐Hodgkin lymphomas
1982
Current approaches to medullary thyroid carcinoma, sporadic and familial
2006
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease
2002
The management of advanced thyroid cancer
2004
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
2017
Thyroid cancer
2016 Standout
Surgical Strategy for the Treatment of Medullary Thyroid Carcinoma
1999
Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform
1997 StandoutNobel
The Thyroid Nodule
2004 Standout
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
2011 Standout
CHOP versus MACOP-B in aggressive lymphoma - a Nordic Lymphoma Group randomised trial
1999
Medullary Thyroid Cancer
1995
Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma
2004
Response criteria for NHL: Importance of ‘normal’ lymph node size and correlations with response rates
2000
Prognostic value of positron emission tomography in the evaluation of post‐treatment residual mass in patients with Hodgkin's disease and non‐Hodgkin's lymphoma
2001
Long-Term Clinical and Biochemical Follow-up in Medullary Thyroid Carcinoma
2007
Medullary Thyroid Carcinoma
2007
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support
1993
Role of serial quantitative gallium-67 tumor uptake in assessing response rates for chemotherapy in lymphoma patients
2008
Extent of Disease and Practice Patterns for Medullary Thyroid Cancer
2005
MEDULLARY THYROID CARCINOMA: A 20‐YEAR EXPERIENCE FROM A CENTRE IN SOUTH INDIA
2007
Sporadic Medullary Microcarcinoma of the Thyroid: A Retrospective Analysis of Eighty Cases
1998
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Postoperative radiotherapy for advanced medullary thyroid cancer—Local disease control in the modern era
2008
External Beam Radiation Therapy for Thyroid Cancer
2008
Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A
2000
On the Added Value of Baseline FDG-PET in Malignant Lymphoma
2009
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease
2006
Prognostic Variables and Calcitonin in Medullary Thyroid Cancer
2005
Circos: An information aesthetic for comparative genomics
2009 Standout
Interferon Alfa Combined with Cytotoxic Chemotherapy for Patients with Non-Hodgkin's Lymphoma
1992
Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.
1994
Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma
2006
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin’s disease and non-Hodgkin’s lymphoma
2002
Rationale for Central and Bilateral Lymph Node Dissection in Sporadic and Hereditary Medullary Thyroid Cancer
2003
IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma.
1997 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival
2000
18F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging
2010
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
2009
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients
1998
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Adjuvant external beam radiation for medullary thyroid carcinoma
2010
Solid Cancers after Bone Marrow Transplantation
1997
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients
2003
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas
1995
Medullary thyroid carcinoma
2004
Determinants of life expectancy in medullary thyroid cancer: age does not matter
2006
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Medullary thyroid carcinoma
2000
The surgical treatment of medullary thyroid carcinoma
1999
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Conventional second‐line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first‐line salvage therapy regimens
2005
Pediatric Hodgkin Lymphoma: Maximizing Efficacy and Minimizing Toxicity
2007
Prognostic Value of Lymph Node Yield and Metastatic Lymph Node Ratio in Medullary Thyroid Carcinoma
2008
Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes
1999 StandoutNobel
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
2005
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Role of Functional Imaging in the Management of Lymphoma
2011
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study.
1987
Increasing frequency of acute myeloid leukemia complicating Hodgkin's disease: A review
1980
Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis.
1987
Revised Response Criteria for Malignant Lymphoma
2007 Standout
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
2001
Die Rolle der externen Strahlentherapie bei der Behandlung des Schilddrüsenkarzinoms
2010
Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis [see comments]
1995
Hashimoto's Disease and Thyroid Lymphoma: Role of the Surgeon
2000
Medullary Thyroid Carcinoma: Management of Lymph Node Metastases
2010
8 Malignant lymphoma in the elderly
1987
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte
2005 Standout
Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases.
2003
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Improved Diagnostic Methods in the Follow-Up of Medullary Thyroid Carcinoma by Highly Specific Calcitonin Measurements*
2000
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
2000
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
A phase I trial combining high-dose 90Y-labeled humanized anti-CEA monoclonal antibody with doxorubicin and peripheral blood stem cell rescue in advanced medullary thyroid cancer.
2005
Chimeric Antigen Receptor Therapy
2018 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Activation of stratospheric chlorine by reactions in liquid sulphuric acid
1994 StandoutNobel
Cancer treatment and survivorship statistics, 2019
2019 Standout
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
The Role of Radiation Therapy in the Treatment of Medullary Thyroid Cancer
2010
Impact of [18F] Fluorodeoxyglucose Positron Emission Tomography on Staging and Management of Early-Stage Follicular Non-Hodgkin Lymphoma
2008
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma
1999
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
A Role for Radiotherapy in the Management of Advanced Medullary Thyroid Carcinoma: the Mayo Clinic Experience
2013
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.
2006
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
State-of-the-Art Therapeutics: Hodgkin's Lymphoma
2005
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma
2009
Follicular lymphoma: prognostic factors for response and survival.
1986
Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work
1997
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Hodgkin's lymphoma
2003
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
2006
Medullary thyroid carcinoma in Hong Kong Chinese patients.
2005
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
Thyroid carcinoma
2003 Standout
Assessment and Significance of Mediastinal Bulk in Hodgkin's Disease: Comparison Between Computed Tomography and Chest Radiography
1999
Psychological problems associated with diagnosis and treatment of lymphomas. I: Retrospective study.
1987
Evidence‐based Approach to the Management of Sporadic Medullary Thyroid Carcinoma
2007
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of S.B. Sutcliffe being referenced
MVPP chemotherapy regimen for advanced Hodgkin's disease
1978
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.
1978
Medullary Thyroid Cancer: Analyses of Survival and Prognostic Factors and the Role of Radiation Therapy in Local Control
1996
Secondary malignancies after bone marrow transplantation in adults.
1994
Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.
1989
The role of surgery in the management of thyroid lymphoma.
1988